A Case of Clinical Application of Covert Sensitization in a Patient with Kleptomania

Jung-Young Kim; Nam-In Kang; Jong-Chul Yang

doi:10.4306/jknpa.2015.54.1.127

Journal List > J Korean Neuropsychiatr Assoc > v.54(1) > 1017724

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim, Kang, and Yang: A Case of Clinical Application of Covert Sensitization in a Patient with Kleptomania

Case Report

Journal of Korean Neuropsychiatric Association 2015; 54(1): 127-131.

Published online: 28 February 2015

DOI: https://doi.org/10.4306/jknpa.2015.54.1.127

A Case of Clinical Application of Covert Sensitization in a Patient with Kleptomania

Jung-Young Kim, MD^1,², Nam-In Kang, MD, PhD², Jong-Chul Yang, MD, PhD^1,³

¹Department of Psychiatry, Chonbuk National University Medical School, Jeonju, Korea.

²Department of Psychiatry, Jeonbuk Provincial Maeumsarang Hospital, Wanju, Korea.

³Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea.

Address for correspondence: Jong-Chul Yang, MD, PhD. Department of Psychiatry, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea. Tel +82-63-250-2580, Fax +82-63-275-3157, yangjc@jbnu.ac.kr

Received 19 December 2014 Revised 27 December 2014 Accepted 30 December 2014

Abstract

Kleptomania is a well-known impulse-control disorder. Although it is a rare disease, it exerts a greater influence on the social and economic. There are a variety of treatments for kleptomania, however case reports of its specific treatment techniques are extremely rare. In this case, covert sensitization was applied to a 44-year-old hospitalized patient with kleptomania, which can facilitate a specific treatment method through case presentation.

Keywords: Kleptomania, Covert sensitization, Cognitive behavior therapy

Notes

The authors have no financial conflicts of interest.

References

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association;2013.

2. Goldman MJ. Kleptomania: making sense of the nonsensical. Am J Psychiatry. 1991; 148:986–996.

3. Grant JE, Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry. 2002; 43:378–384.

4. Koran LM, Aboujaoude EN, Gamel NN. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J Clin Psychiatry. 2007; 68:422–427.

5. Grant JE, Kim SW, Odlaug BL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009; 65:600–606.

6. Grant JE. Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci. 2006; 43:81–87.

7. Grant JE, Potenza MN. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004; 16:27–34.

8. Grant JE, Odlaug BL. [Kleptomania: clinical characteristics and treatment]. Rev Bras Psiquiatr. 2008; 30:Supple 1. S11–S15.

9. Grant JE, Odlaug BL, Davis AA, Kim SW. Legal consequences of kleptomania. Psychiatr Q. 2009; 80:251–259.

10. Presta S, Marazziti D, Dell'Osso L, Pfanner C, Pallanti S, Cassano GB. Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry. 2002; 43:7–12.

11. Fishbain DA. Kleptomania as risk-taking behavior in response to depression. Am J Psychother. 1987; 41:598–603.

12. McElroy SL, Pope HG Jr, Hudson JI, Keck PE Jr, White KL. Kleptomania: a report of 20 cases. Am J Psychiatry. 1991; 148:652–657.

TOOLS

Similar articles